- Home
- LAZ vs ALVO Comparison
LAZ vs ALVO Comparison
Compare LAZ & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZ
- ALVO
- Stock Information
- Founded
- LAZ 1848
- ALVO 2013
- Country
- LAZ United States
- ALVO Luxembourg
- Employees
- LAZ N/A
- ALVO N/A
- Industry
- LAZ Investment Managers
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- LAZ Finance
- ALVO Health Care
- Exchange
- LAZ Nasdaq
- ALVO Nasdaq
- Market Cap
- LAZ 4.1B
- ALVO 3.4B
- IPO Year
- LAZ 2005
- ALVO N/A
- Fundamental
- Price
- LAZ $38.64
- ALVO $7.94
- Analyst Decision
- LAZ Hold
- ALVO Buy
- Analyst Count
- LAZ 7
- ALVO 1
- Target Price
- LAZ $46.83
- ALVO $18.00
- AVG Volume (30 Days)
- LAZ 1.6M
- ALVO 151.4K
- Earning Date
- LAZ 04-25-2025
- ALVO 05-20-2025
- Dividend Yield
- LAZ 5.18%
- ALVO N/A
- EPS Growth
- LAZ N/A
- ALVO N/A
- EPS
- LAZ 2.87
- ALVO N/A
- Revenue
- LAZ $2,932,289,000.00
- ALVO $491,978,000.00
- Revenue This Year
- LAZ N/A
- ALVO $33.92
- Revenue Next Year
- LAZ $12.53
- ALVO $45.74
- P/E Ratio
- LAZ $13.45
- ALVO N/A
- Revenue Growth
- LAZ 6.93
- ALVO 426.85
- 52 Week Low
- LAZ $31.97
- ALVO $7.35
- 52 Week High
- LAZ $61.14
- ALVO $14.76
- Technical
- Relative Strength Index (RSI)
- LAZ 47.61
- ALVO 29.94
- Support Level
- LAZ $33.45
- ALVO $8.04
- Resistance Level
- LAZ $40.22
- ALVO $8.75
- Average True Range (ATR)
- LAZ 2.53
- ALVO 0.56
- MACD
- LAZ 0.73
- ALVO 0.05
- Stochastic Oscillator
- LAZ 80.41
- ALVO 36.20
About LAZ Lazard Inc.
Lazard has a storied history that can be traced back to 1848. The company's revenue is fairly evenly split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily driven by equities (over 80% of assets under management), has an international focus, and targets institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.